TARO Annual CFF
N/A
31 March 2024
Summary:
TARO annual cash flow from financing activities is not available.TARO Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TARO Quarterly CFF
N/A
31 March 2024
Summary:
TARO quarterly cash flow from financing activities is not available.TARO Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TARO TTM CFF
N/A
31 March 2024
Summary:
TARO TTM cash flow from financing activities is not available.TARO TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TARO Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
TARO Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time |
Taro Pharmaceutical Industries Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2023 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2022 | - | $0.00(0.0%) | $0.00(-100.0%) |
| June 2022 | - | $0.00(0.0%) | -$6.62 M(-73.5%) |
| Mar 2022 | -$24.93 M(+3.1%) | $0.00(0.0%) | -$24.93 M(-45.7%) |
| Dec 2021 | - | $0.00(-100.0%) | -$45.89 M(-6.6%) |
| Sept 2021 | - | -$6.62 M(-63.9%) | -$49.13 M(+15.6%) |
| June 2021 | - | -$18.32 M(-12.6%) | -$42.52 M(+75.7%) |
| Mar 2021 | -$24.20 M(-10.3%) | -$20.95 M(+546.1%) | -$24.20 M(+611.6%) |
| Dec 2020 | - | -$3.24 M(<-9900.0%) | -$3.40 M(-87.4%) |
| Sept 2020 | - | $0.00(0.0%) | -$26.98 M(0.0%) |
| June 2020 | - | $0.00(-100.0%) | -$26.98 M(0.0%) |
| Mar 2020 | -$26.98 M(-95.4%) | -$157.00 K(-99.4%) | -$26.98 M(-37.9%) |
| Dec 2019 | - | -$26.83 M(<-9900.0%) | -$43.48 M(-92.2%) |
| Sept 2019 | - | $0.00(0.0%) | -$556.45 M(-1.4%) |
| June 2019 | - | $0.00(-100.0%) | -$564.19 M(-4.2%) |
| Mar 2019 | -$588.85 M(+450.4%) | -$16.66 M(-96.9%) | -$588.85 M(-5.7%) |
| Dec 2018 | - | -$539.79 M(+6865.9%) | -$624.26 M(+530.7%) |
| Sept 2018 | - | -$7.75 M(-68.6%) | -$98.97 M(-19.6%) |
| June 2018 | - | -$24.66 M(-52.6%) | -$123.15 M(+15.1%) |
| Mar 2018 | -$106.99 M(-63.7%) | -$52.06 M(+259.0%) | -$106.99 M(+33.6%) |
| Dec 2017 | - | -$14.50 M(-54.6%) | -$80.11 M(-15.4%) |
| Sept 2017 | - | -$31.93 M(+276.1%) | -$94.70 M(-44.6%) |
| June 2017 | - | -$8.49 M(-66.3%) | -$170.90 M(-42.0%) |
| Mar 2017 | -$294.90 M(+1822.7%) | -$25.18 M(-13.4%) | -$294.90 M(+5.6%) |
| Dec 2016 | - | -$29.09 M(-73.1%) | -$279.16 M(+9.3%) |
| Sept 2016 | - | -$108.13 M(-18.4%) | -$255.51 M(+73.1%) |
| June 2016 | - | -$132.49 M(+1302.0%) | -$147.60 M(+862.3%) |
| Mar 2016 | -$15.34 M(+40.5%) | -$9.45 M(+73.7%) | -$15.34 M(+151.2%) |
| Dec 2015 | - | -$5.44 M(+2306.6%) | -$6.11 M(-44.3%) |
| Sept 2015 | - | -$226.00 K(+1.3%) | -$10.97 M(+0.2%) |
| June 2015 | - | -$223.00 K(+1.8%) | -$10.95 M(+0.2%) |
| Mar 2015 | -$10.92 M | -$219.00 K(-97.9%) | -$10.92 M(+1.2%) |
| Dec 2014 | - | -$10.30 M(+5051.5%) | -$10.79 M(-94.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2014 | - | -$200.00 K(+2.0%) | -$204.25 M(+0.2%) |
| June 2014 | - | -$196.00 K(+125.3%) | -$203.78 M(+0.2%) |
| Mar 2014 | -$203.46 M(+6017.3%) | -$87.00 K(-100.0%) | -$203.46 M(+0.7%) |
| Dec 2013 | - | -$203.77 M(<-9900.0%) | -$202.02 M(+2704.3%) |
| Sept 2013 | - | $272.00 K(+123.0%) | -$7.20 M(+5.6%) |
| June 2013 | - | $122.00 K(-91.0%) | -$6.82 M(+105.1%) |
| Mar 2013 | -$3.33 M(-49.5%) | $1.35 M(-115.1%) | -$3.33 M(-28.9%) |
| Dec 2012 | - | -$8.95 M(-1470.4%) | -$4.68 M(-27.4%) |
| Sept 2012 | - | $653.00 K(-82.0%) | -$6.44 M(-17.0%) |
| June 2012 | - | $3.62 M(-133.8%) | -$7.76 M(+91.7%) |
| Mar 2012 | -$6.59 M(+62.7%) | - | - |
| Dec 2011 | -$4.05 M(-95.3%) | -$10.71 M(+1498.5%) | -$4.05 M(-94.5%) |
| Sept 2011 | - | -$670.00 K(-81.7%) | -$72.95 M(+11.0%) |
| June 2011 | - | -$3.66 M(-133.3%) | -$65.69 M(-15.1%) |
| Mar 2011 | - | $10.99 M(-113.8%) | -$77.41 M(-10.1%) |
| Dec 2010 | -$86.11 M(+201.3%) | -$79.62 M(-1308.3%) | -$86.11 M(+1225.4%) |
| Sept 2010 | - | $6.59 M(-142.9%) | -$6.50 M(-50.4%) |
| June 2010 | - | -$15.37 M(-773.2%) | -$13.09 M(-673.2%) |
| Mar 2010 | - | $2.28 M | $2.28 M |
| Dec 2009 | -$28.58 M(-1.2%) | - | - |
| Dec 2008 | -$28.92 M(-221.8%) | - | - |
| Dec 2007 | $23.74 M(-178.2%) | - | - |
| Dec 2006 | -$30.36 M(-573.9%) | - | - |
| Dec 2005 | $6.41 M(-90.7%) | - | - |
| Dec 2004 | $69.17 M(-45.8%) | - | - |
| Dec 2003 | $127.65 M(>+9900.0%) | - | - |
| Dec 2002 | $192.00 K(-99.9%) | - | - |
| Dec 2001 | $136.99 M(+1071.6%) | - | - |
| Dec 2000 | $11.69 M(+68.4%) | - | - |
| Dec 1999 | $6.95 M(+98.4%) | - | - |
| Dec 1998 | $3.50 M(-44.4%) | - | - |
| Dec 1997 | $6.30 M(-16.0%) | - | - |
| Dec 1996 | $7.50 M(+78.6%) | - | - |
| Dec 1995 | $4.20 M(+31.3%) | - | - |
| Dec 1994 | $3.20 M(-45.8%) | - | - |
| Dec 1993 | $5.90 M(-31.4%) | - | - |
| Dec 1992 | $8.60 M(+152.9%) | - | - |
| Dec 1991 | $3.40 M | - | - |
FAQ
- What is the all time high annual CFF for Taro Pharmaceutical Industries?
- What is the all time high quarterly CFF for Taro Pharmaceutical Industries?
- What is the all time high TTM CFF for Taro Pharmaceutical Industries?
What is the all time high annual CFF for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high annual cash flow from financing activities is $136.99 M
What is the all time high quarterly CFF for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high quarterly cash flow from financing activities is $10.99 M
What is the all time high TTM CFF for Taro Pharmaceutical Industries?
Taro Pharmaceutical Industries all-time high TTM cash flow from financing activities is $2.28 M